|
MKI67 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.736200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.683800E-01 |
| Normal-vs-Stage2 |
9.035800E-02 |
| Normal-vs-Stage3 |
5.897800E-01 |
| Normal-vs-Stage4 |
9.690600E-01 |
| Stage1-vs-Stage2 |
5.66749999999505E-05 |
| Stage1-vs-Stage3 |
7.350400E-01 |
| Stage1-vs-Stage4 |
4.453600E-01 |
| Stage2-vs-Stage3 |
5.021400E-03 |
| Stage2-vs-Stage4 |
2.676600E-03 |
| Stage3-vs-Stage4 |
3.812000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.694200E-01 |
| Normal-vs-AfricanAmerican |
3.642200E-01 |
| Normal-vs-Asian |
5.289800E-01 |
| Caucasian-vs-AfricanAmerican |
1.977380E-01 |
| Caucasian-vs-Asian |
3.794000E-01 |
| AfricanAmerican-vs-Asian |
5.800800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.091400E-01 |
| Normal-vs-Female |
5.661200E-01 |
| Male-vs-Female |
8.822000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.425000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.285400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.254000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.701200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.412400E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.884980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.635900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.823780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.927800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.515700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.973800E-01 |
| Classical-VS-Follicular |
1.01969999999341E-06 |
| Classical-VS-Other |
8.957600E-03 |
| Classical-VS-Normal |
8.284400E-01 |
| Tall-VS-Follicular |
1.015830E-02 |
| Tall-VS-Other |
2.279700E-02 |
| Tall-VS-Normal |
8.688600E-01 |
| Follicular-VS-Other |
9.227800E-01 |
| Follicular-VS-Normal |
7.685700E-02 |
| Other-VS-Normal |
1.038590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.491800E-01 |
| Normal-vs-N1 |
4.650200E-01 |
| N0-vs-N1 |
6.779000E-01 |
|
|
